Abstract
Aims The purpose of this review was to investigate the effect of different types of maternal anemia interventions on serum hemoglobin levels among pregnant cohort of reproductive age during COVID-19 pandemic using a pool of studies conducted with different research designs.
Methods Relevant studies were identified from January 2020 to December 2022 by using MeSH terms in PubMed, Embase, Cochrane Library, Clinical trials, Scopus databases and gray literature. The studies were systematically reviewed, and quality assessments were evaluated by the guidelines of the Cochrane risk of bias. All the statistical analysis was performed on RevMan 5.4.1 software with a random and fixed effect models. Heterogeneity was evaluated with the Cochran Q statistic and Higgins test and publication bias assessed via funnel plots. The cumulative pooled effect of maternal anemia interventions (n = 15) on serum hemoglobin concentration was the main outcome, while effects of specific types of maternal anemia interventions; mode of administration; and the country a study was conducted were derived as secondary outcomes. In total, 6695 pregnant women of reproductive age were established from the entire pool of studies. Mean serum hemoglobin levels’ data were retrieved alongside their standard errors for ascertaining the effect of the said maternal anemia interventions on hemoglobin levels using f standard mean and mean differences during meta-analysis. The review component was part of registered PROSPERO: CRD-CRD42023410657:[
Results Fifteen studies met the inclusion criteria, with the current study findings proposing that, maternal anemia interventions in overall improved serum hemoglobin levels [SMD (95% CI) = 0.93 [0.57, 1.30]; Heterogeneity: Tau-squared = 0.50; Chi-squared = 627.07, df = 14 (P < 0.00001); I-squared = 98%. The effect of specific intervention categories was; dietary iron supplement 1.16 [95% CI = −0.97, 3.28], education information 0.75 [95% CI = 0.12, 1.37], Intravenous ferric carboxy-maltose 1.33 [95% CI = 0.28, 2.38], intravenous iron sucrose 0.82 [95% CI = 0.56, 1.09] and herbal substances 0.42 [95% CI = 0.24, 0.61]. Dietary iron supplementation didn’t demonstrate an improvement on hemoglobin levels (Test for overall effect: Z = 1.07 (P = 0.29). Parenterally given and via education administered interventions had better utility on hemoglobin concentrations with maternal anemia interventions among developing countries showing insignificant effect on maternal serum hemoglobin levels.
Conclusion Current review concluded that maternal anemia interventions had a utility on serum hemoglobin, more feasible, those given as injections. Notably, dietary iron interventions were compromised especially in developing nations during COVID-19 pandemic. Multifaceted further clinical studies are crucial to substantiate current findings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Partially by KMTC, Kenya
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.